Cargando…
Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis
BACKGROUND: To explore the significance of SAA in evaluating the severity and prognosis of COVID-19. METHODS: A total of 132 patients with confirmed COVID-19 who were admitted to a designated COVID-19 hospital in Wuhan, China from January 18, 2020 to February 26, 2020 were collected. The dynamic cha...
Autores principales: | Li, Huan, Xiang, Xiaochen, Ren, Hongwei, Xu, Lingli, Zhao, Lisha, Chen, Xiaoqiong, Long, Hui, Wang, Qiang, Wu, Qingming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of The British Infection Association.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141628/ https://www.ncbi.nlm.nih.gov/pubmed/32277967 http://dx.doi.org/10.1016/j.jinf.2020.03.035 |
Ejemplares similares
-
D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis
por: Long, Hui, et al.
Publicado: (2020) -
Serum amyloid A‐to‐albumin ratio as a potential biomarker to predict the activity, severity, and poor prognosis of systemic lupus erythematosus
por: Zhao, Liang, et al.
Publicado: (2022) -
Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis
por: Cho, W C S, et al.
Publicado: (2010) -
Role of Serum Amyloid A as a Biomarker for Predicting the Severity and Prognosis of COVID-19
por: Abbas, Amal A., et al.
Publicado: (2022) -
Abnormal myocardial enzymes are important indicators of poor prognosis in COVID-19 patients
por: Cheng, Jingping, et al.
Publicado: (2021)